Missouri Trust & Investment Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.6K Hold
910
0.02% 191
2025
Q4
$71.9K Hold
910
0.02% 193
2025
Q3
$72.7K Sell
910
-36
-4% -$3.07K 0.02% 194
2025
Q2
$86K Buy
946
+36
+4% +$3.29K 0.03% 166
2025
Q1
$85.3K Hold
910
0.03% 169
2024
Q4
$82.7K Hold
910
0.03% 173
2024
Q3
$94.5K Hold
910
0.03% 163
2024
Q2
$88.3K Hold
910
0.03% 159
2024
Q1
$81.9K Hold
910
0.03% 165
2023
Q4
$72.5K Hold
910
0.03% 168
2023
Q3
$64.7K Hold
910
0.03% 165
2023
Q2
$70.1K Buy
910
+400
+78% +$31K 0.04% 165
2023
Q1
$38.3K Hold
510
0.02% 186
2022
Q4
$40K Hold
510
0.02% 187
2022
Q3
$36K Hold
510
0.02% 192
2022
Q2
$41K Hold
510
0.03% 186
2022
Q1
$39K Hold
510
0.02% 200
2021
Q4
$44K Buy
+510
New +$39.8K 0.03% 209

Other funds holding CL

Missouri Trust & Investment Company's CL Position: Q1 2026 in Review

Missouri Trust & Investment Company held its Colgate-Palmolive (CL) position steady in Q1 2026 at 910 shares worth $77.6K. The position accounts for 0.02% of the portfolio, ranked #191.

Missouri Trust & Investment Company first reported a position in CL in Q4 2021 and has held it in 18 quarters since. The position peaked at $94.5K in Q3 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Missouri Trust & Investment Company held 910 shares of Colgate-Palmolive worth $77.6K as of Q1 2026.
  • Missouri Trust & Investment Company left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.02% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #191 holding.
  • Missouri Trust & Investment Company first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • Missouri Trust & Investment Company's Colgate-Palmolive position peaked at $94.5K in Q3 2024.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.